Skip to content

← All stories

Markets

Guggenheim lowers Enliven Therapeutics stock price target to $78

1 source ·1 article ·Aug 6, 12:26 UTC Enliven Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·Aug 6, 12:26 UTC

Guggenheim lowers Enliven Therapeutics stock price target to $78